BCR and mantle cell lymphoma: The combinatorial treatment of BCR and non-canonical Wnt signaling can be of particular importance in CLL and MCL where it has been shown earlier that in these malignancies the non-canonical Wnt pathway and BCR signaling can be targeted in a combinatorial manner.